Step 1: Recognize that we know nothing about treating MI in ICU patients.
Step 2: Checking a troponin level on every ICU patient isn’t wise.
Step 3: Clinical history and EKG is a reasonable way to screen for ischemia in ICU patients.
Step 4: Troponin elevation is often not due to MI at all.
Step 5: Most myocardial infarctions in the ICU are type-2 MIs.
Step 6: Heparin infusion is not beneficial unless the patient is scheduled for cardiac catheterization.
Step 7: Prophylactic dose fondaparinux is a reasonable approach to anticoagulate a type-1 MI patient who isn’t going for cardiac catheterization.
- IBCC chapter – Disseminated Intravascular Coagulation (DIC) - January 18, 2021
- PulmCrit- RCTs don't justify using convalescent plasma or antibody cocktails - January 14, 2021
- PulmCrit – Six RCTs to answer one question: what is the role of tocilizumab in COVID-19? - January 12, 2021